You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RB1 germline mutation

Showing 1 - 25 of 3,041
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Searching for Novel Germline Mutations in Lobular Breast Cancer

Recruiting
  • Lobular Breast Carcinoma
  • +3 more
  • Illumina panel
  • Milan, Italy
    European Institute of Oncology
Sep 12, 2022

Breast & Ovarian Cancer Risk Detection

Recruiting
  • Adnexal Mass
  • +3 more
  • OVA360
  • Austin, Texas
    Silvana Franco
Jul 20, 2022

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

BRCA1 Mutation, Breast Cancer, Breast Diseases Trial in United States (Denosumab, Placebo, Quality-of-Life Assessment)

Not yet recruiting
  • BRCA1 Mutation
  • +5 more
  • (no location specified)
Jul 19, 2021

Women With BRCA1 Germline Deleterious Mutation Trial in France (Blood sampling)

Completed
  • Women With BRCA1 Germline Deleterious Mutation
  • Blood sampling
  • Lyon, France
  • +3 more
Jan 18, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Breast Cancer Trial in France (Main study:, Sub-study:)

Recruiting
  • Breast Cancer
  • Main study:
  • Sub-study:
  • Bordeaux, France
  • +20 more
Jan 2, 2023

Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

Completed
  • Ovarian Cancer
  • Breast Cancer
  • Ahmedabad, India
  • +15 more
Oct 28, 2022

InheriteD brEast caNcer iTalian regIsTrY A

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +11 more
    Apr 26, 2023

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +6 more
    • (no location specified)
    Mar 28, 2023

    BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma

    Active, not recruiting
    • Choroidal Nevi, Uveal Melanoma
      • Houston, Texas
      • +2 more
      Mar 24, 2021

      MAstectomy With Reconstruction Including Robot Endoscopic

      Recruiting
      • Breast Neoplasms
      • +4 more
      • Robotic or endoscopic nipple sparing mastectomy
      • Conventional mastectomy (including nipple sparing mastectomy, skin sparing mastectomy)
      • Seoul, Korea, Republic of
        Yonsei University College of Medicine
      Jun 4, 2021

      GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

      Not yet recruiting
      • GATA2 Gene Mutation
      • Biological samples (blood and bone marrow samples).
      • Angers, France
      • +16 more
      Jul 31, 2023

      Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

      Active, not recruiting
      • Pancreatic Cancer
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Nov 10, 2021

      Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

      Recruiting
      • Ovarian Cancer
      • Phoenix, Arizona
      • +116 more
      Nov 25, 2022

      Germline Mutations Associated With Hereditary Pancreatic Cancer

      Recruiting
      • Pancreatic Cancer
      • Pancreatic Adenocarcinoma
      • Invitae Multi-Cancer Panel ®
      • Mexico City, Mexico
        Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
      Mar 22, 2022

      Ovarian Cancer Trial in Shanghai (IMP4297)

      Unknown status
      • Ovarian Cancer
      • Shanghai, China
        Xiaohua.Wu
      Nov 22, 2020

      Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation Trial in Shanghai (Fluzoparib;

      Recruiting
      • Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation
      • Fluzoparib; Apatinib
      • +2 more
      • Shanghai, China
        Jiangsu HengRui Medicine Co., Ltd.
      Aug 6, 2020

      A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • +4 more
        • Guangzhou, Guangdong, China
          Cancer Center, Sun Yat-sen University
        Oct 25, 2022

        Prostate Cancer, Familial Prostate Cancer Trial (Panel sequencing, whole exome sequencing, whole genome sequencing)

        Not yet recruiting
        • Prostate Cancer
        • Familial Prostate Cancer
        • Panel sequencing, whole exome sequencing, whole genome sequencing
        • (no location specified)
        Dec 26, 2022

        Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,

        Completed
        Has Results
        • Neoplasms, Breast
        • +5 more
        • Tucson, Arizona
        • +103 more
        Nov 2, 2021